Thymic epithelial tumors: examining the gtf2i mutation and developing a novel prognostic signature with lncrna pairs to predict tumor recurrence

HIGHLIGHTS

• who: Wei Liu from the Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China have published the research: Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence, in the Journal: (JOURNAL)
• what: The authors first examined the TIME differences between GTF2I mutant and wild-type TETs based on The study provides multiple potential immunotherapeutic targets such as CD2. The study has identified immune checkpoints requiring further investigation. The study showed that the lncRNAs CCDC144NLAS1 and LINC01748 may also . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.